Inhibrx, Inc.

NasdaqGM:INBX.V Voorraadrapport

Marktkapitalisatie: US$1.8b

Inhibrx Beheer

Beheer criteriumcontroles 3/4

Inhibrx's CEO is Mark Lappe, appointed in Jan 2010, has a tenure of 14.33 years. total yearly compensation is $2.80M, comprised of 24.1% salary and 75.9% bonuses, including company stock and options. directly owns 5.81% of the company’s shares, worth $103.89M. The average tenure of the management team and the board of directors is 3.3 years and 3.3 years respectively.

Belangrijke informatie

Mark Lappe

Algemeen directeur

US$2.8m

Totale compensatie

Percentage CEO-salaris24.1%
Dienstverband CEO14.3yrs
Eigendom CEO5.8%
Management gemiddelde ambtstermijn3.3yrs
Gemiddelde ambtstermijn bestuur3.3yrs

Recente managementupdates

Geen updates

Recent updates

Analyse CEO-vergoeding

Hoe is Mark Lappe's beloning veranderd ten opzichte van Inhibrx's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Mar 31 2024n/an/a

-US$271m

Dec 31 2023US$3mUS$675k

-US$241m

Sep 30 2023n/an/a

-US$189m

Jun 30 2023n/an/a

-US$172m

Mar 31 2023n/an/a

-US$163m

Dec 31 2022US$1mUS$650k

-US$145m

Sep 30 2022n/an/a

-US$125m

Jun 30 2022n/an/a

-US$111m

Mar 31 2022n/an/a

-US$94m

Dec 31 2021US$5mUS$650k

-US$82m

Sep 30 2021n/an/a

-US$78m

Jun 30 2021n/an/a

-US$78m

Mar 31 2021n/an/a

-US$75m

Dec 31 2020US$869kUS$530k

-US$76m

Sep 30 2020n/an/a

-US$75m

Jun 30 2020n/an/a

-US$74m

Mar 31 2020n/an/a

-US$68m

Dec 31 2019US$864kUS$450k

-US$51m

Compensatie versus markt: Mark's total compensation ($USD2.80M) is below average for companies of similar size in the US market ($USD5.66M).

Compensatie versus inkomsten: Mark's compensation has increased whilst the company is unprofitable.

CEO

Mark Lappe (56 yo)

14.3yrs

Tenure

US$2,802,021

Compensatie

Mr. Mark Paul Lappe is Co-founded Inhibrx LLC in 2010. Mr. Lappe co-founded Efficacy Capital Limited in 2004 serves as its President and Managing Partner. Mr. Lappe co-founded Inhibrx in 2010 and serves as...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Mark Lappe
Founder14.3yrsUS$2.80m5.81%
$ 103.9m
Brendan Eckelman
Founder & Chief Scientific Officer14.1yrsUS$1.45m4.5%
$ 80.3m
Kelly Deck
Executive VP & CFO4.1yrsUS$1.15m0%
$ 0
Quinn Deveraux
Founderno datageen gegevensgeen gegevens
Ashraf Amanullah
Executive VP & Chief Technical Operations Officerno datageen gegevensgeen gegevens
Leah Pollema
VP, Corporate Secretary & General Counselno datageen gegevensgeen gegevens
Charbel Helaihel
Vice President of Marketing & Commercial Planning1.3yrsgeen gegevensgeen gegevens
Jeffrey Jensen
Executive VP & Chief Clinical Operations Officer4.3yrsgeen gegevensgeen gegevens
David Matly
Executive VP and Chief Commercial & Business Development Officer2.6yrsgeen gegevensgeen gegevens
Carlos Bais
Executive Vice President of Translational Sciences2yrsgeen gegevensgeen gegevens
Josep Garcia
EVP & Chief Clinical Development Officer1.1yrsgeen gegevensgeen gegevens

3.3yrs

Gemiddelde duur

49.5yo

Gemiddelde leeftijd

Ervaren management: INBX.V's management team is considered experienced (3.3 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Mark Lappe
Founder14.3yrsUS$2.80m5.81%
$ 103.9m
Stephen Howell
Member of Advisory Boardno datageen gegevensgeen gegevens
Rand Mulford
Member of Advisory Boardno datageen gegevensgeen gegevens
Douglas Forsyth
Independent Director6.1yrsUS$317.03k1.14%
$ 20.4m
Kimberly Manhard
Independent Director3.9yrsUS$298.03k0%
$ 0
John Kayyem
Independent Director6.1yrsUS$306.53k6.25%
$ 111.7m
Victor Nizet
Member of Advisory Boardno datageen gegevensgeen gegevens
Guy Salvesen
Scientific Advisorno datageen gegevensgeen gegevens
Kristiina Vuori
Independent Director2.6yrsUS$300.53k0%
$ 0
Igor Barjaktarevic
Member of INBRX-101 Scientific Advisory Board2.1yrsgeen gegevensgeen gegevens
Mark Brantly
Member of INBRX-101 Scientific Advisory Board2.1yrsgeen gegevensgeen gegevens
Kenneth Chapman
Member of INBRX-101 Scientific Advisory Board2.1yrsgeen gegevensgeen gegevens

3.3yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren bestuur: INBX.V's board of directors are considered experienced (3.3 years average tenure).